These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10954386)

  • 1. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia.
    Dean B
    Aust N Z J Psychiatry; 2000 Aug; 34(4):560-9. PubMed ID: 10954386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is psychosis a neurobiological syndrome?
    Fujii DE; Ahmed I
    Can J Psychiatry; 2004 Nov; 49(11):713-8. PubMed ID: 15633848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
    Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic dysfunction in schizophrenia.
    Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
    Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.
    Gao XM; Sakai K; Roberts RC; Conley RR; Dean B; Tamminga CA
    Am J Psychiatry; 2000 Jul; 157(7):1141-9. PubMed ID: 10873924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking.
    Sommer W; Hyytiä P; Kiianmaa K
    Addict Biol; 2006 Sep; 11(3-4):289-309. PubMed ID: 16961760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M; Soubrouillard C; Blin O
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The biological mechanisms underlying alcohol dependence].
    Alling C
    Lakartidningen; 1999 Jul; 96(28-29):3248-52. PubMed ID: 10434508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia.
    Werkman TR; Glennon JC; Wadman WJ; McCreary AC
    CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):3-23. PubMed ID: 16613551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
    Deakin FW; Simpson MD; Slater P; Hellewell JS
    J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating novel targets for pharmacological interventions in schizophrenia.
    Wroblewska B; Lewis DA
    Am J Psychiatry; 2009 Jul; 166(7):753-6. PubMed ID: 19570936
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia.
    Dean B
    Clin Exp Pharmacol Physiol; 2001; 28(1-2):74-8. PubMed ID: 11153542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain.
    Benes FM
    Arch Gen Psychiatry; 1995 Dec; 52(12):1015-8; discussion 1019-24. PubMed ID: 7492253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular pathology of schizophrenia].
    Uezato A; Nishikawa T
    Nihon Rinsho; 2013 Apr; 71(4):591-8. PubMed ID: 23678584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia].
    Kornhuber J; Weller M
    Nervenarzt; 1994 Nov; 65(11):741-54. PubMed ID: 7816150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.